Cerence and Expensify Announce Strong Free Cash Flow Guidance and Share Repurchase Programs

Cerence and Expensify have both announced robust free cash flow guidance for fiscal year 2026, with Cerence projecting $76M-$82M and Expensify $12M-$14M. Both companies are also launching share repurchase programs, with Cerence initiating a $30M program.